BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 718333)

  • 1. Spontaneous regression of breast carcinoma.
    Krutchik AN; Buzdar AU; Blumenschein GR; Lukeman JM
    Arch Intern Med; 1978 Nov; 138(11):1734-5. PubMed ID: 718333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous regression of breast carcinoma: follow-up report and literature review.
    Ross MB; Buzdar AU; Hortobagyi GN; Lukeman JM
    J Surg Oncol; 1982 Jan; 19(1):22-4. PubMed ID: 7057640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patient with pleural involvement by breast carcinoma.
    Poe RH; Qazi R; Israel RH; Wicks CM; Rubins JM
    Am J Clin Oncol; 1983 Oct; 6(5):523-7. PubMed ID: 6613918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metastatic pleural effusions from MAMMA carcinoma (author's transl)].
    Leue G
    Z Erkr Atmungsorgane; 1977; 147(1):73-8. PubMed ID: 868136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic contribution of carcinoembryonic antigen (CEA) in the pleural fluid and serum of patients with metastatic pleural effusion caused by neoplasm of the breast].
    Rapellino M; Obert R; Pecchio F; Casadio C; Oliaro A; Paisio B
    Minerva Med; 1987 Jan; 78(2):103-5. PubMed ID: 3808402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural beta-interferon for local use in the treatment of metastatic pleural effusion caused by neoplasm of the breast].
    Terzoli E; Izzo F; Lucatelli S; Ranuzzi M
    G Ital Oncol; 1989; 9(2-3):53-7. PubMed ID: 2767729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
    Ciampa A; Fanger G; Khan A; Rock KL; Xu B
    Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of metastatic breast carcinoma with cardiac tamponade and pleural effusion showing long survival by local treatment combined with systemic chemotherapy].
    Shimizu M; Sakauchi G; Mukai S; Sakamoto T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1636-9. PubMed ID: 1530323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations and management of malignant pleural effusions in breast carcinoma.
    el-Mahdi A; Levene A; Lott S
    Johns Hopkins Med J; 1973 Jan; 132(1):44-9. PubMed ID: 4682662
    [No Abstract]   [Full Text] [Related]  

  • 10. Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Imoto S; Yokose T; Ishii G; Iwasaki M; Wada N
    Hum Pathol; 2008 May; 39(5):681-93. PubMed ID: 18329692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous regression of malignant lymphoma of the breast.
    Iihara K; Yamaguchi K; Nishimura Y; Iwasaki T; Suzuki K; Hirabayashi Y
    Pathol Int; 2004 Jul; 54(7):537-42. PubMed ID: 15189510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous regression of breast cancer.
    Lewison EF
    Natl Cancer Inst Monogr; 1976 Nov; 44():23-6. PubMed ID: 799758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleural effusion in breast cancer: influence upon clinical course and survival.
    Singer TS; Sulkes A; Biran S
    Chemioterapia; 1986 Feb; 5(1):66-9. PubMed ID: 3955787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of pleural effusion secondary to breast carcinoma responding to treatment based upon thoracoscopic findings].
    Hirai T; Nishiuchi M; Ushio K; Koro T; Shinji Y; Taniguchi S
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):685-8. PubMed ID: 2321987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eyelid metastasis from breast cancer showing marked response to chemotherapy.
    Zhang GJ; Adachi I; Yin DF; Narabayashi M; Tokue Y; Watanabe T; Kaneko A; Tsuda H; Abe K
    Jpn J Clin Oncol; 1995 Feb; 25(1):10-5. PubMed ID: 7877258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On diagnostic and therapeutic problems of the metastasizing breast carcinoma].
    Hatzenberger H
    Krebsarzt; 1969; 24(3):153-60. PubMed ID: 5809856
    [No Abstract]   [Full Text] [Related]  

  • 18. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7. Management of advanced breast cancer.
    Rubens RD
    Int J Clin Pract; 2001 Dec; 55(10):676-9. PubMed ID: 11777292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
    Ohta Y; Shimizu Y; Matsumoto I; Watanabe G
    J Exp Clin Cancer Res; 2006 Mar; 25(1):15-9. PubMed ID: 16761613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.